These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15336824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy].
    Spirito P, Piccininno M.
    Ital Heart J Suppl; 2000 Jun; 1(6):840-1. PubMed ID: 11204022
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy].
    Primo JJ.
    Rev Port Cardiol; 2001 Feb; 20(2):225-8. PubMed ID: 11293882
    [No Abstract] [Full Text] [Related]

  • 6. Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.
    Bos JM, Maron BJ, Ackerman MJ, Haas TS, Sorajja P, Nishimura RA, Gersh BJ, Ommen SR.
    Am J Cardiol; 2010 Nov 15; 106(10):1481-6. PubMed ID: 21059440
    [Abstract] [Full Text] [Related]

  • 7. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
    Maron BJ, Maron MS, Lesser JR, Hauser RG, Haas TS, Harrigan CJ, Appelbaum E, Main ML, Roberts WC.
    Am J Cardiol; 2008 Feb 15; 101(4):544-7. PubMed ID: 18312775
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
    Mercereau D, Kubac G, Klinke WP.
    Can J Cardiol; 1989 Mar 15; 5(2):77-80. PubMed ID: 2706577
    [Abstract] [Full Text] [Related]

  • 10. [Hypertrophic cardiomyopathy. Arrhythmia in hypertrophic cardiomyopathy].
    Colín Lizalde Lde J.
    Arch Cardiol Mex; 2003 Mar 15; 73 Suppl 1():S26-30. PubMed ID: 12966640
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr 15; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Anti-arrhythmic drugs interaction and defibrillation threshold in patients with implantable cardioverter defibrillator].
    de Vasconcelos JT, Galvão Filho Sdos S, Barcellos CM.
    Arq Bras Cardiol; 2003 Mar 15; 80(3):336-9. PubMed ID: 12856278
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ventricular Fibrillation Refractory to Cutaneous Electrical Defibrillation in a Morbidly Obese Pediatric Patient With Hypertrophic Cardiomyopathy: A Case Report.
    Gylys MH, Rajan G.
    A A Pract; 2019 Sep 15; 13(6):201-203. PubMed ID: 31008723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.